デフォルト表紙
市場調査レポート
商品コード
986414

大麻製剤の世界市場 - 市場シェア・市場規模・動向・業界分析レポート:製品 (Epidiolex、Marinol、Cesamet、Sativex)・流通チャネル・地域・セグメント別の予測 (2020~2027年)

Cannabis Pharmaceuticals Market Share, Size, Trends, Industry Analysis Report, By Product (Epidiolex, Marinol, Cesamet, Sativex); By Distribution Channel; By Regions; Segment Forecast, 2020 - 2027

出版日: | 発行: Polaris Market Research | ページ情報: 英文 104 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.72円
大麻製剤の世界市場 - 市場シェア・市場規模・動向・業界分析レポート:製品 (Epidiolex、Marinol、Cesamet、Sativex)・流通チャネル・地域・セグメント別の予測 (2020~2027年)
出版日: 2020年12月01日
発行: Polaris Market Research
ページ情報: 英文 104 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界における大麻製剤の市場規模は、2027年までに57億2000万米ドルへ達すると予測されています。

市場における有利な法律、先進諸国にわたる政策、および大麻入り薬剤の研究開発に対する投資は、市場の成長に貢献する重要な要因です。さらに、最新のデリバリー手法で大麻入り薬剤の正確な投与量を決定する技術革新により、成人の薬物乱用を抑制するための治療的・精神活性イベントを確実にし、大麻製剤の市場成長も促進します。

当レポートでは、世界の大麻製剤市場について調査し、市場の概要と動向、各セグメント・地域別の動向分析と市場シェア、競合情勢、および主要企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

  • レポートの説明
    • 調査目的
    • 市場範囲
    • 前提条件
  • ステークホルダー

第2章 エグゼクティブサマリー

  • 市場ハイライト

第3章 調査手法

  • 概要
    • データマイニング
  • データソース
    • 一次ソース
    • 二次ソース

第4章 大麻製剤市場の考察

  • 業界のスナップショット
  • 市場力学
    • 推進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
    • 供給企業の交渉力(中)
    • 新規参入者の脅威:(低)
    • 買い手の交渉力(中)
    • 代替の脅威(中)
    • 既存企業間の競争(高)
  • PESTLE分析
  • 業界の動向

第5章 大麻製剤の市場評価:製品別

  • 主な調査結果
  • イントロダクション
    • 世界の大麻製剤市場:製品別 (金額ベース)
  • Sativex
    • 世界の大麻製剤市場:Sativex - 地域別 (金額ベース)
  • Epidiolex
    • 世界の大麻製剤市場:Epidiolex - 地域別 (金額ベース)
  • Marinol
    • 世界の大麻製剤市場:Marinol - 地域別 (金額ベース)
  • Cesamet
    • 世界の大麻医薬品市場:Cesamet - 地域別 (金額ベース)

第6章 大麻製剤の市場評価:流通チャネル別

  • 主な調査結果
  • イントロダクション
    • 世界の大麻製剤市場:流通チャネル別 (金額ベース)
  • 病院薬局
    • 世界の大麻製剤市場:病院薬局 - 地域別 (金額ベース)
  • オンライン薬局
    • 世界の大麻製剤市場:オンライン薬局 - 地域別 (金額ベース)
  • 小売薬局
    • 世界の大麻製剤市場:小売薬局 - 地域別 (金額ベース)

第7章 大麻製剤の市場評価:地域別

  • 主な調査結果
  • イントロダクション
    • 大麻製剤市場の評価:地域別 (金額ベース)
  • 北米市場
    • 製品別 (金額ベース)
    • 流通チャネル別 (金額ベース)
    • 米国
    • カナダ
  • 欧州市場
    • 製品別 (金額ベース)
    • 流通チャネル別 (金額ベース)
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • オーストリア
  • アジア太平洋市場
    • 製品別 (金額ベース)
    • 流通チャネル別 (金額ベース)
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
  • 中東・アフリカ市場
    • 製品別 (金額ベース)
    • 流通チャネル別 (金額ベース)
    • サウジアラビア
    • UAE
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ市場
    • 製品別 (金額ベース)
    • 流通チャネル別 (金額ベース)
    • メキシコ
    • ブラジル
    • アルゼンチン

第8章 競合情勢

  • 拡張と買収の分析
    • 拡張
    • 買収
  • パートナーシップ/コラボレーション/契約/展示会

第9章 企業プロファイル

  • GW Pharmaceuticals
  • Valeant Pharmaceuticals
  • Insys Therapeutics, Inc.
  • Corbus Pharmaceuticals
  • Teva Pharmaceutical
  • Avicanna
  • Solvay Pharmaceuticals
  • Sprint Corporation
  • Cannabics Pharmaceuticals
  • Kao Corporation
図表

List of Tables

  • Table 1 Global Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 2 Global Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 3 Cannabis Pharmaceuticals Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • Table 4 North America: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 5 North America: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 6 U.S.: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 7 U.S.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 8 Canada: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 9 Canada: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 10 Europe: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 11 Europe: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 12 UK: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 13 UK: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 14 France: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 15 France: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 16 Germany: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 17 Germany: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 18 Italy: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 19 Italy: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 20 Spain: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 21 Spain: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 22 Netherlands: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 23 Netherlands: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 24 Austria: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 25 Austria: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 26 Asia Pacific: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 27 Asia Pacific: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 28 China: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 29 China: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 30 India: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 31 India: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 32 Malaysia: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 33 Malaysia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 34 Japan: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 35 Japan: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 36 Indonesia: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 37 Indonesia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 38 South Korea: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 39 South Korea: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 40 Middle East & Africa: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 41 Middle East & Africa: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 42 Saudi Arabia: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 43 Saudi Arabia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 44 UAE: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 45 UAE: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 46 Israel: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 47 Israel: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 48 South Africa: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 49 South Africa: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 50 Latin America: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 51 Latin America: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 52 Mexico: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 53 Mexico: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 54 Brazil: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 55 Brazil: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 56 Argentina: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • Table 57 Argentina: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)

List of Figures

Figure 1 Market Highlights (2019, Revenue)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top Down & Bottom Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by Product

Figure 7 Global Cannabis Pharmaceuticals Market, By Product, 2019 & 2027 (USD Million)

Figure 8 Market by Distribution Channel

Figure 9 Global Cannabis Pharmaceuticals Market, By Distribution Channel, 2019 & 2027 (USD Million)

Figure 10 Cannabis Pharmaceuticals Market Assessment, By Geography, 2016 - 2027 (USD Million)

Figure 11 Strategic Analysis - Cannabis Pharmaceuticals Market

目次
Product Code: PM1773

The global cannabis pharmaceuticals market is expected to reach USD 5.72 billion by 2027, according to a new study by Polaris Market Research. The report "Cannabis Pharmaceuticals Market Share, Size, Trends, Industry Analysis Report, By Product (Epidiolex, Marinol, Cesamet and Sativex); By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), By Regions; Segment Forecast, 2020 - 2027" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Favorable legislation in the market, policies across developed economies, and investments in the research and development for cannabis-infused drugs are the key factors responsible for the market growth. Moreover, technological innovation to decide the accurate dose of cannabis-infused drugs with cutting edge delivery methods to ensure therapeutic and psychoactive events, to contain drug abuse among adults also favoring market growth for cannabis pharmaceuticals. Blockchain technology in the pharmaceutical industry could be used to maintain strain purity and product formulations to have effective treatment for the therapeutic cause and will also enable us to capture dosage data for future considerations, thus technology could also play important role in shaping the market future of the cannabis pharmaceuticals industry.

The global market for cannabis pharmaceuticals is fragmented based on product, distribution channel, and region. In terms of product, the market is segmented into Epidiolex, Marinol, Cesamet, and Sativex. Based on distribution channel, the cannabis pharmaceuticals industry is further bifurcated into hospital, online, and retail pharmacies.

Segment Highlights

Sativex segment accounted for the largest revenue share in 2019 owing to the growing usage of drug for the muscle spasticity. In addition, growing demand for plant-based pharmaceuticals is expected to drive market demand for cannabis pharmaceuticals.

Based on distribution channel, the hospitals pharmacies segment is projected to account for a significant share by 2027. The high share is attributed to the fact that most of the physicians recommend medicines from in-house pharmacy stores driving the cannabis medicines market growth.

Europe accounted for the largest share in 2019 in terms of revenue on account of the increasing demand for plant-based medicines and the increasing awareness pertaining to the medicinal benefits associated cannabis

List of Key Players:

GW Pharmaceuticals

Valeant Pharmaceuticals

Insys Therapeutics, Inc.

Corbus Pharmaceuticals

Teva Pharmaceutical

Avicanna

Solvay Pharmaceuticals

Cannabics Pharmaceuticals

Others

Polaris Market Research has segmented the cannabis pharmaceuticals market report on the basis of product, distribution channel, and region

Cannabis Pharmaceuticals, Product Outlook (Revenue - USD Million, 2016 - 2027)

Sativex

Marinol

Cesamet

Epidiolex

Cannabis Pharmaceuticals, Distribution Channel Outlook (Revenue - USD Million, 2016 - 2027)

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Cannabis Pharmaceuticals, Regional Outlook (Revenue - USD Million, 2016 - 2027)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Cannabis Pharmaceuticals Market Insights

  • 4.1. Cannabis Pharmaceuticals - Industry snapshot
  • 4.2. Cannabis Pharmaceuticals Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased use in different therapeutic areas
      • 4.2.1.2. Increased support in the form of clinical evidence
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Shelf life of cannabidiol and cross reactions
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Cannabis Pharmaceuticals Market Industry trends

5. Cannabis Pharmaceuticals Market Assessment by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
  • 5.3. Sativex
    • 5.3.1. Global Cannabis Pharmaceuticals Market, by Sativex, by Region, 2016 - 2027 (USD Million)
  • 5.4. Epidiolex
    • 5.4.1. Global Cannabis Pharmaceuticals Market, by Epidiolex, by Region, 2016 - 2027 (USD Million)
  • 5.5. Marinol
    • 5.5.1. Global Cannabis Pharmaceuticals Market, by Marinol, by Region, 2016 - 2027 (USD Million)
  • 5.6. Cesamet
    • 5.6.1. Global Cannabis Pharmaceuticals Market, by Cesamet, by Region, 2016 - 2027 (USD Million)

6. Global Cannabis Pharmaceuticals Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Global Cannabis Pharmaceuticals Market, by Hospital Pharmacies, By Region, 2016 - 2027 (USD Million)
  • 6.4. Online Pharmacies
    • 6.4.1. Global Cannabis Pharmaceuticals Market, by Online Pharmacies, by Region, 2016 - 2027 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Global Cannabis Pharmaceuticals Market, by Retail Pharmacies, by Region, 2016 - 2027 (USD Million)

7. Cannabis Pharmaceuticals Market Assessment by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Cannabis Pharmaceuticals Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • 7.3. Cannabis Pharmaceuticals Market - North America
    • 7.3.1. North America: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
    • 7.3.2. North America: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.3.3. Cannabis Pharmaceuticals Market - U.S.
      • 7.3.3.1. U.S.: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.3.3.2. U.S.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.3.4. Cannabis Pharmaceuticals Market - Canada
      • 7.3.4.1. Canada: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.3.4.2. Canada.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 7.4. Cannabis Pharmaceuticals Market - Europe
    • 7.4.1. Europe: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
    • 7.4.2. Europe: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.3. Cannabis Pharmaceuticals Market - UK
      • 7.4.3.1. UK: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.3.2. UK: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.4. Cannabis Pharmaceuticals Market - France
      • 7.4.4.1. France: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.4.2. France: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.5. Cannabis Pharmaceuticals Market - Germany
      • 7.4.5.1. Germany: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.5.2. Germany: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.6. Cannabis Pharmaceuticals Market - Italy
      • 7.4.6.1. Italy: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.6.2. Italy: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.7. Cannabis Pharmaceuticals Market - Spain
      • 7.4.7.1. Spain: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.7.2. Spain: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.8. Cannabis Pharmaceuticals Market - Netherlands
      • 7.4.8.1. Netherlands: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.8.2. Netherlands: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.4.9. Cannabis Pharmaceuticals Market - Austria
      • 7.4.9.1. Austria: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.4.9.2. Austria: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 7.5. Cannabis Pharmaceuticals Market - Asia-Pacific
    • 7.5.1. Asia Pacific: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
    • 7.5.2. Asia Pacific: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.5.3. Cannabis Pharmaceuticals Market - China
      • 7.5.3.1. China: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.5.3.2. China: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.5.4. Cannabis Pharmaceuticals Market - India
      • 7.5.4.1. India: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.5.4.2. India.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.5.5. Cannabis Pharmaceuticals Market - Malaysia
      • 7.5.5.1. Malaysia: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.5.5.2. Malaysia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.5.6. Cannabis Pharmaceuticals Market - Japan
      • 7.5.6.1. Japan: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.5.6.2. Japan: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.5.7. Cannabis Pharmaceuticals Market - Indonesia
      • 7.5.7.1. Indonesia: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.5.7.2. Indonesia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.5.8. Cannabis Pharmaceuticals Market - South Korea
      • 7.5.8.1. South Korea: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.5.8.2. South Korea.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 7.6. Cannabis Pharmaceuticals Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
    • 7.6.2. Middle East & Africa.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.6.3. Cannabis Pharmaceuticals Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.6.3.2. Saudi Arabia.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.6.4. Cannabis Pharmaceuticals Market - UAE
      • 7.6.4.1. UAE: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.6.4.2. UAE: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.6.5. Cannabis Pharmaceuticals Market - Israel
      • 7.6.5.1. Israel: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.6.5.2. Israel: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.6.6. Cannabis Pharmaceuticals Market - South Africa
      • 7.6.6.1. South Africa: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.6.6.2. South Africa: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 7.7. Cannabis Pharmaceuticals Market - Latin America
    • 7.7.1. Latin America: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
    • 7.7.2. Latin America: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.7.3. Cannabis Pharmaceuticals Market - Mexico
      • 7.7.3.1. Mexico: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.7.3.2. Mexico.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.7.4. Cannabis Pharmaceuticals Market - Brazil
      • 7.7.4.1. Brazil: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.7.4.2. Brazil.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 7.7.5. Cannabis Pharmaceuticals Market - Argentina
      • 7.7.5.1. Argentina: Cannabis Pharmaceuticals Market, By Product, 2016 - 2027 (USD Million)
      • 7.7.5.2. Argentina.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 - 2027 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisition
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. GW Pharmaceuticals
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Valeant Pharmaceuticals
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Insys Therapeutics, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Corbus Pharmaceuticals
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Teva Pharmaceutical
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Avicanna
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Solvay Pharmaceuticals
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Sprint Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Cannabics Pharmaceuticals
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Kao Corporation
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development